Cargando…

Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease

Inflammatory bowel disease complications can be related to inflammatory bowel disease-related pulmonary diseases or a form of hypersensitivity pneumonitis secondary to the immunosuppressive medications. We present a patient with intermittent chest pain and hypoxic respiratory failure who was found t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobecki, Jeffrey, Patel, Kruti, Kahl, Ryan, Minaudo, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145167/
https://www.ncbi.nlm.nih.gov/pubmed/32309496
http://dx.doi.org/10.14309/crj.0000000000000302
_version_ 1783519946414751744
author Sobecki, Jeffrey
Patel, Kruti
Kahl, Ryan
Minaudo, Mark
author_facet Sobecki, Jeffrey
Patel, Kruti
Kahl, Ryan
Minaudo, Mark
author_sort Sobecki, Jeffrey
collection PubMed
description Inflammatory bowel disease complications can be related to inflammatory bowel disease-related pulmonary diseases or a form of hypersensitivity pneumonitis secondary to the immunosuppressive medications. We present a patient with intermittent chest pain and hypoxic respiratory failure who was found to have balsalazide-induced pneumonitis. We discuss the treatment and long-term outlook.
format Online
Article
Text
id pubmed-7145167
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer
record_format MEDLINE/PubMed
spelling pubmed-71451672020-04-17 Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease Sobecki, Jeffrey Patel, Kruti Kahl, Ryan Minaudo, Mark ACG Case Rep J Case Report Inflammatory bowel disease complications can be related to inflammatory bowel disease-related pulmonary diseases or a form of hypersensitivity pneumonitis secondary to the immunosuppressive medications. We present a patient with intermittent chest pain and hypoxic respiratory failure who was found to have balsalazide-induced pneumonitis. We discuss the treatment and long-term outlook. Wolters Kluwer 2020-01-20 /pmc/articles/PMC7145167/ /pubmed/32309496 http://dx.doi.org/10.14309/crj.0000000000000302 Text en © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Case Report
Sobecki, Jeffrey
Patel, Kruti
Kahl, Ryan
Minaudo, Mark
Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease
title Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease
title_full Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease
title_fullStr Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease
title_full_unstemmed Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease
title_short Balsalazide-Induced Pneumonitis Causing Dyspnea in a Patient With Inflammatory Bowel Disease
title_sort balsalazide-induced pneumonitis causing dyspnea in a patient with inflammatory bowel disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145167/
https://www.ncbi.nlm.nih.gov/pubmed/32309496
http://dx.doi.org/10.14309/crj.0000000000000302
work_keys_str_mv AT sobeckijeffrey balsalazideinducedpneumonitiscausingdyspneainapatientwithinflammatoryboweldisease
AT patelkruti balsalazideinducedpneumonitiscausingdyspneainapatientwithinflammatoryboweldisease
AT kahlryan balsalazideinducedpneumonitiscausingdyspneainapatientwithinflammatoryboweldisease
AT minaudomark balsalazideinducedpneumonitiscausingdyspneainapatientwithinflammatoryboweldisease